Proposed Data Collections Submitted for Public Comment and Recommendations, 16791-16792 [E7-6340]

Download as PDF 16791 Federal Register / Vol. 72, No. 65 / Thursday, April 5, 2007 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued No. of responses/ respondent Avg. burden/ response in hours Type of respondent Survey instruments No. of respondents Teacher .................................. Teacher Survey (Attachment B35) ......................................... 4154 ............... 1 10/60 Total ................................ ................................................................................................. 961 children ... 892 parents .... 4154 teachers ........................ ........................ Dated: March 30, 2007. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–6339 Filed 4–4–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60 Day–07–07AU] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Joan Karr, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. ongoing MRSA prevention efforts at hospitals reporting to CDC surveillance systems is unknown. CDC has developed a survey to assess MRSA prevention programs in place at health care facilities reporting MRSA infection data to CDC through established surveillance systems. In this project, infection control practitioners in all 220 hospitals that participate in the MRSA portion of the Active Bacterial Core Surveillance System will surveyed electronically three times. There will be an initial baseline survey and then two follow-up surveys, each a year apart. The surveys will determine if changes in infection control practice correlate with changes in rates of MRSA infections. The proposed survey will provide data that can be used to assess progress toward achieving CDC’s Health Protection Goals. The survey will also provide data on facility-based MRSA prevention policies and procedures that may affect MRSA infection rates. These results will inform CDC in the prevention and control of MRSA. This proposed project supports CDC’s Goal of ‘‘Healthy People in Healthy Places’’ and its Strategic Goal to ‘‘Increase the number of health care institutions that comply with evidence based guidelines for infection control.’’ There is no cost to respondents other than their time to complete the survey. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Survey to Assess Methicillin-Resistant Staphylococcus aureus (MRSA) Prevention Programs among Hospitals Participating in CDC MRSA Surveillance Programs—New—National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID) (proposed), Centers for Disease Control and Prevention. Background and Brief Description In October, 2006, CDC recommended specific strategies to reduce transmission of multi-drug resistant organisms, including MRSA, in U.S. hospitals. Currently detailed data on ESTIMATE OF ANNUALIZED BURDEN HOURS Number of respondents Respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) 220 1 15/60 55 Total .......................................................................................................... jlentini on PROD1PC65 with NOTICES Hospital Infection Control Professionals .......................................................... ........................ ........................ ........................ 55 VerDate Aug<31>2005 17:37 Apr 04, 2007 Jkt 211001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\05APN1.SGM 05APN1 16792 Federal Register / Vol. 72, No. 65 / Thursday, April 5, 2007 / Notices Dated: March 30, 2007. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–6340 Filed 4–4–07; 8:45 am] BILLING CODE 4163–18–P this research will give scientists and health professionals greater insight into the airborne transmission of disease and allow them to better assess the potential effectiveness of preventive measures. The first part of this study will measure the quantity and size distribution of aerosol produced during human coughs. To accomplish this, volunteers will cough into a spirometer, which is a commonly used piston-like medical device that measures the volume of air exhaled by a patient. After the volunteer coughs into the spirometer, the air in the spirometer will be drawn into a commercial aerosol measurement device. These experiments will also provide information on how much cough aerosols vary over time for individuals and how much aerosol generation varies between individuals. The second part of this study will determine how effectively surgical masks and N95 respirators block coughgenerated aerosols. N95 respirators are dust masks that are certified to filter out at least 95% of airborne material during normal breathing. N95 respirators are known to be more effective than surgical masks at filtering out airborne particles during inhalation, but it is not known whether masks or respirators are more effective at blocking cough-generated aerosols. For this work, masks and respirators will be placed in a special holder with a disposable mouthpiece, and human subjects will cough into the mouthpiece and through the mask. The aerosol produced by each subject will be analyzed before and after flowing through the mask. These experiments will determine how effective each mask or respirator is at preventing the release of cough-generated aerosols. Volunteers from part 1 may also participate in part 2 if they wish. There will be no costs to study participants other than their time. on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Centers for Disease Control and Prevention Aerosol Generation by Cough— NEW—The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). [60 Day–07–06AP] Background and Brief Description Proposed Data Collections Submitted for Public Comment and Recommendations The Federal Occupational Safety and Health Act of 1970, section 501, enables NIOSH to carry out research relevant to the health and safety of workers. NIOSH is conducting a two-year study of airborne clouds of particles or droplets called ‘‘aerosols’’. Some diseases like influenza and Severe Acute Respiratory Syndrome (SARS) can be spread when people produce infectious aerosols by coughing or sneezing. Aerosol transmission of infectious diseases is especially important to health-care workers and emergency responders, who face a much greater risk of exposure to these hazards than does the general public. Cough-generated aerosols are of particular concern because coughing is one of the most common symptoms of respiratory infections. However, substantial gaps exist in our understanding about the generation of aerosols during coughing. This lack of information hampers the ability of health scientists to model and predict the generation of infectious aerosols by coughing and to understand whether or not cough-generated aerosols are likely to be an important means of transmission of particular diseases. The purpose of this study is to gain a better understanding of the production of aerosols by coughing. The results of DEPARTMENT OF HEALTH AND HUMAN SERVICES In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–4766 and send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information ESTIMATE OF ANNUALIZED BURDEN HOURS Number of respondents Respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) 20 120 5 1 1.5 1.5 150 180 Total .......................................................................................................... jlentini on PROD1PC65 with NOTICES Part 1 participants ............................................................................................ Part 2 participants ............................................................................................ ........................ ........................ ........................ 330 VerDate Aug<31>2005 17:37 Apr 04, 2007 Jkt 211001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\05APN1.SGM 05APN1

Agencies

[Federal Register Volume 72, Number 65 (Thursday, April 5, 2007)]
[Notices]
[Pages 16791-16792]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6340]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60 Day-07-07AU]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Joan Karr, CDC Acting Reports Clearance Officer, 
1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to 
omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Survey to Assess Methicillin-Resistant Staphylococcus aureus (MRSA) 
Prevention Programs among Hospitals Participating in CDC MRSA 
Surveillance Programs--New--National Center for Preparedness, 
Detection, and Control of Infectious Diseases (NCPDCID) (proposed), 
Centers for Disease Control and Prevention.

Background and Brief Description

    In October, 2006, CDC recommended specific strategies to reduce 
transmission of multi-drug resistant organisms, including MRSA, in U.S. 
hospitals. Currently detailed data on ongoing MRSA prevention efforts 
at hospitals reporting to CDC surveillance systems is unknown. CDC has 
developed a survey to assess MRSA prevention programs in place at 
health care facilities reporting MRSA infection data to CDC through 
established surveillance systems. In this project, infection control 
practitioners in all 220 hospitals that participate in the MRSA portion 
of the Active Bacterial Core Surveillance System will surveyed 
electronically three times. There will be an initial baseline survey 
and then two follow-up surveys, each a year apart. The surveys will 
determine if changes in infection control practice correlate with 
changes in rates of MRSA infections. The proposed survey will provide 
data that can be used to assess progress toward achieving CDC's Health 
Protection Goals. The survey will also provide data on facility-based 
MRSA prevention policies and procedures that may affect MRSA infection 
rates. These results will inform CDC in the prevention and control of 
MRSA.
    This proposed project supports CDC's Goal of ``Healthy People in 
Healthy Places'' and its Strategic Goal to ``Increase the number of 
health care institutions that comply with evidence based guidelines for 
infection control.''
    There is no cost to respondents other than their time to complete 
the survey.

                                       Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden  per    Total burden
                   Respondents                      respondents    responses per   response  (in    (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Hospital Infection Control Professionals........             220               1           15/60              55
�������������������������������������������������
    Total.......................................  ..............  ..............  ..............              55
----------------------------------------------------------------------------------------------------------------



[[Page 16792]]

    Dated: March 30, 2007.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E7-6340 Filed 4-4-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.